Please assess the completion status of the following clinical trial:

Trial Title: Garcinia Mangostana L.Pericarp Gel as a Local Drug Delivery in Treatment of Chronic Periodontitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age: 30 to 65 years~* Systemically healthy subjects with chronic periodontitis~Exclusion Criteria:~* aggressive periodontitis,~* systemic disorders,~* known or suspected allergy to the MGA/placebo group,~* pregnant and lactating females,~* long term steroid medication,~* smokers,~* alcoholics,~* immunocompromised individuals and~* those with history of antibiotic or periodontal therapy in preceding 6 months

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- Garcinia Mangostana (Type: ACTIVE_COMPARATOR): The constituents of mangostana containing gel were prepared under the following proportions: Mangostana powder - 4gm, Gelatin - 12gm, Glycerin (wetting agent) - 0.2ml, Peppermint oil (flavouring agent) - 0.1ml, sodium saccharine (sweetening agent) - 0.1ml and purified water q.s 100ml.
- Placebo gel (Type: PLACEBO_COMPARATOR): The placebo gel was prepared with Gelatin - 12gm, Glycerin (wetting agent) - 0.2ml, Peppermint oil (flavouring agent) - 0.1ml, sodium saccharine (sweetening agent) - 0.1ml and purified water q.s 100ml excluding the active ingredient mangostana powder - 4 mg and maintaining same physical properties such as color and taste.

Based on this trial design, predict the completion outcome and termination type (if applicable).